Renal Cancer
Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management.
January 24, 2019
Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers.
January 24, 2019
NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
January 23, 2019
Association between age and sex and mortality after adjuvant therapy for renal cancer.
January 23, 2019
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma.
January 22, 2019
Clinicopathologic and Genomic Factors Associated With Oncologic Outcome in Patients With Stage III to IV Chromophobe Renal Cell Carcinoma.
January 22, 2019
Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation.
January 22, 2019
Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells.
January 21, 2019
Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer.
January 21, 2019
α-1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Clear Cell Renal Cell Carcinoma.
January 18, 2019
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
January 18, 2019
Grading of renal cell carcinoma.
January 18, 2019
Renal cell carcinoma staging: pitfalls, challenges, and updates.
January 18, 2019
A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma.
January 17, 2019